AN IN VITRO COST-EFFECTIVE TEST BENCH FOR ACTIVE CARDIAC IMPLANTS, REPRODUCING HUMAN EXPOSURE TO ELECTRIC FIELDS 50 HZ

[1]World Health Organization. Global Status Report on Non communicable Diseases 2014; Geneva, Switzerland, 2014. Search in Google Scholar

[2]Greenspon A. J., Patel J. D., Lau E., Ochoa J., FrischD. R., Ho R. T., Pavri B. B. andKurtz M. S. Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009. Journal of the American College of Cardiology, 2012, 60: 1540–1545.10.1016/j.jacc.2012.07.01722999727 Search in Google Scholar

[3]Kurtz S.M., Ochoa J.A., Lau E., Shkolnikov Y., Pavri B.B., Frisch D. and Greenspon A.J. Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993-2006: Implantation Trends and Patient Profiles For Pacemakers And ICDs’. Pacing and Clinical Electrophysiology, 2010, 33(6): 705–711, 2010. Search in Google Scholar

[4]Directive 2013/35/EU of the European Parliament and the Council. On the minimum health and safety requirements regarding the exposure of workers to the risks arising from physical agents (electromagnetic fields). Official Journal of the European Union, 2013, L179: 1-21. Search in Google Scholar

[5]CENELEC - EN 50527-1:2016; Procedure for the assessment of the exposure to EM fields of workers bearing active implantable medical devices – Part 1: General. 2016 Search in Google Scholar

[6]CENELEC - EN 50527-2-1:2016 ; Procedure for the assessment of the exposure to electromagnetic fields of workers bearing active implantable medical devices - Part 2-1: Specific assessment for workers with cardiac pacemakers. 2016 (revised version to be published in spring 2017). Search in Google Scholar

[7]Stuchly M. A., Kavet R. Numerical modeling of pacemaker interference in the electric-utility environment. IEEE Transactions on Device and Materials Reliability, 2005, 5: 481–487.10.1109/TDMR.2005.859576 Search in Google Scholar

[8]Katrib J., Nadi M., Kourtiche D., Schmitt P., Magne I. and Roth P. Evaluation of low frequency magnetic field exposure system for ICDs for in vitro studies. Third European IRPA Congress ; Radiation protection – science, safety and securityJune 2010, Helsinki, Finland. Search in Google Scholar

[9]IEC 62226-3-1. Exposure to electric or magnetic fields in the low and intermediate frequency range - Methods for calculating the current density and internal electric field induced in the human body - Part 3-1: Exposure to electric fields - Analytical and 2D numerical models. Ed. 2016. Search in Google Scholar

[10]Weiland T. A numerical method for the solution of the eigenwave problem of longitudinally homogeneous waveguides. Electronics and Communication, 1977, 31(7): 308-314. Search in Google Scholar

[11]Katrib J., Nadi M., Kourtiche D., Magne I., Schmitt P., Souques M. and Roth P. In vitro assessment of the immunity of implantable cardioverter-defibrillators to magnetic fields of 50/60 Hz. Physiological Measurement, 2013, 34: 1281–92.10.1088/0967-3334/34/10/128124021865 Search in Google Scholar

[12]Nelson J. J., Clement W., Martel B., Kautz R. and Nelson K. H. Assessment of active implantable medical device interaction in hybrid electric vehicles. in 2008 IEEE International Symposium on Electromagnetic Compatibility, 2008, pp. 1–6.10.1109/ISEMC.2008.4652064 Search in Google Scholar

[13]Gercek C., Kourtiche D., Schmitt P., Magne I., Souques M., Roth P. and Nadi M. Computation of Pacemakers Immunity to 50 Hz Electric Field: Induced Voltages 10 times greater in unipolar than in bipolar detection mode, MDPI – Bioengineering, submitted 23 December 2016, Manuscript ID : bioengineering-171952, Manuscript Status : Under review 10.3390/bioengineering4010019559043228952498 Search in Google Scholar

[14]Findlay R. P. Induced electric fields in the MAXWEL surface-based human model from exposure to external low frequency electric fields. Radiation Protection Dosimetry, 2014, 162(3):244–253.10.1093/rpd/nct28124218644 Search in Google Scholar

[15]Kavet R., Stuchly M. A., Bailey W. H. and Bracken T. D.. Evaluation of biological effects, dosimetric models, and exposure assessment related to ELF electric- and magnetic-field guidelines. Appl Occup Environ Hyg, 2001, 16(12): 1118–1138.10.1080/1047322012741211783873 Search in Google Scholar

[16]ICRP 2002. Basic anatomical and physiological data for use in radiological protection: reference values. ICRP Publication 89 Ann. 2002, 32, 5–265. Search in Google Scholar

[17]Medtronic® Official website, Pacemaker Leads – Overview. http://www.medtronic.com/us-en/healthcare-professionals/products/cardiac-rhythm/pacemakers/pacing-leads.html (accessed Oct 27, 2016). Search in Google Scholar

[18]International Commission on Non-Ionizing Radiation Protections, Guidelines for limiting exposure to time-varying electric and magnetic fields (1 Hz to 100 kHz), Health Physics, vol. 99, no. 6, pp. 818–836, 2010.10.1097/HP.0b013e3181f06c8621068601 Search in Google Scholar

[19]I. Magne, F. Audran, E. Mayaudon, D. Clement, and F. Deschamps, 50 Hz Electric and Magnetic Field Measurements in High Voltage Substations: Technical Report, REE. Revue de l’électricité et de l’électronique, vol. 77, no. 5, pp. 32–36, 2010. Search in Google Scholar

[20]Dyrda K., Nguyen D.H., Plante M., Turgeon A., Khairy P., Thibault B., Andrade J., Dubuc M., Guerra P.G., Macle L., Mondesert B., Rivard L., Roy D., Talajic M. and Ostiguy G. Interference Resistance of Pacemakers and Defibrillators to 60 Hz Electric Fields, Canadian Journal of Cardiology, 2015, 31(10): S233–S234.10.1016/j.cjca.2015.07.493 Search in Google Scholar

[21]Korpinen L., Kuisti H., Elovaara J. and Virtanen V. Cardiac Pacemakers in Electric and Magnetic Fields of 400-kV Power Lines. Pacing and Clinical Electrophysiology, 2012, 35(4): 422–430.10.1111/j.1540-8159.2011.03327.x22309463 Search in Google Scholar

[22]Korpinen L., Kuisti H., Elovaara J. and Virtanen V. Implantable Cardioverter Defibrillators in Electric and Magnetic Fields of 400 kV Power Lines: Implantable cardioverter defibrillators in fields, Pacing and Clinical Electrophysiology, 2014, vol. 37, no. 3, pp. 297–303.10.1111/pace.1227024033389 Search in Google Scholar

[23]Seckler T., Stunder D., Schikowsky C., Joosten S., Zink M. D., Kraus T., Marx N., Napp A. Effect of lead position and orientation on electromagnetic interference in patients with bipolar cardiovascular implantable electronic device, Europace, 2016.10.1093/europace/euv45828173083 Search in Google Scholar

[24]Napp A. et al., Electromagnetic Interference With Implantable Cardioverter-Defibrillators at Power Frequency An In Vivo Study, Circulation, 2014, vol. 129, no. 4, pp. 441–450.10.1161/CIRCULATIONAHA.113.00308124163067 Search in Google Scholar

[25]Joosten S., Pammler K., and Silny J. The influence of anatomical and physiological parameters on the interference voltage at the input of unipolar cardiac pacemakers in low frequency electric fields, Physics in Medicine and Biology, 2009, vol. 54, no. 3, pp. 591–609.10.1088/0031-9155/54/3/00819124951Search in Google Scholar